National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 710 cases where Vaccine targets COVID-19 (COVID19) and Manufacturer is JANSSEN and Write-up contains 'thrombosis'



Case Details

This is page 12 out of 71

Result pages: prev   3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21   next


VAERS ID: 1241054 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Pennsylvania  
Vaccinated:0000-00-00
Onset:2021-04-14
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Patient has no family history of thrombosis.
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210431723

Write-up: BLOOD CLOT IN LEFT CALF; This spontaneous report received from a patient and concerned a female of unspecified age. The patient was called to obtain additional information on 21-APR-2021 and message was left on a voicemail. The patient''s height, and weight were not reported. The patient has no family history of thrombosis. The patient does not have any underlying conditions. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 14-APR-2021, the subject experienced blood clot in left calf. The patient noted that she did not have any underlying conditions or family history that may have made her more predisposed to this diagnosis. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from blood clot in left calf. This report was serious (Other Medically Important Condition).; Sender''s Comments: V0: This spontaneous report concerns a female patient of unspecified age who experienced a blood clot one day after Janssen COVID-19 vaccine was administered for prevention of symptomatic SARS-CoV-2 virus infection. The patient''s height, and weight were not reported. The patient has no family history of thrombosis and has not reported any underlying conditions. No concomitant medications were reported. The patient did not provide details related to the blood clot, except it was not resolved at the time of the report. Given lack of alternative explanation and temporal plausibility the event is considered possibly related to Janssen COVID-19 vaccine.


VAERS ID: 1241684 (history)  
Form: Version 2.0  
Age: 25.0  
Sex: Female  
Location: California  
Vaccinated:2021-04-08
Onset:2021-04-09
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 041A21A / 1 RA / IM

Administered by: Other       Purchased by: ?
Symptoms: Cerebral haemorrhage, Deep vein thrombosis, Prothrombin level normal
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 14 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: labetolol, prenatal vitamin
Current Illness: pregnancy; delivered by C-section 4/1/21
Preexisting Conditions: morbid obesity BMI 44
Allergies: penicillin, amoxicillin
Diagnostic Lab Data: initial factors were elevated but normalized now one week later with negative for factor V Leiden. sister has factor V Leiden and factor VIII and also had a stroke postpartum 4 years ago but this patient has no permanent factor abnormalities yet identified. ACLA and LAC normal.
CDC Split Type:

Write-up: admitted to hospital that evening with acute intracerebral hemorrhage felt to be from a cerebral venous thrombosis with dense left hemiplegia. one week later, developed bilateral upper extremity cephalic vein thrombosis that the following week, 4/21/21, continued to propagate


VAERS ID: 1242429 (history)  
Form: Version 2.0  
Age: 64.0  
Sex: Male  
Location: Florida  
Vaccinated:2021-03-27
Onset:2021-04-03
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Axillary vein thrombosis, Pain in extremity, Peripheral swelling, Ultrasound scan abnormal
SMQs:, Cardiac failure (broad), Angioedema (broad), Embolic and thrombotic events, venous (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: testosterone gel, fluticasone propionate NS, omeprazole, zolpidem prn
Current Illness: none
Preexisting Conditions: male hypogonadism/ low testosterone, seasonal allergic rhinitis, GERD w Barrett''s, insomnia
Allergies: aspirin, shellfish, iodine products,,beesting
Diagnostic Lab Data: as above, venous ultrasound left upper extremity 4/16/2021
CDC Split Type:

Write-up: developed swelling and pain left arm within 1 week of administration Janssen Covid -19 vaccine IM left arm on 3/27/2021, on 4/16/21 left upper extremity venous sonogram demonstrated left axillary vein thrombosis


VAERS ID: 1242683 (history)  
Form: Version 2.0  
Age: 53.0  
Sex: Male  
Location: Unknown  
Vaccinated:2021-04-09
Onset:2021-04-21
   Days after vaccination:12
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / SYR

Administered by: Unknown       Purchased by: ?
Symptoms: Basal ganglia haemorrhage, Cerebrovascular accident, Deep vein thrombosis, Ultrasound Doppler abnormal
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Nifedipine
Current Illness:
Preexisting Conditions: Hypertension
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Deep Vein Thrombosis- occlusive and non-occlusive in R axial and R brachial veins at level of PICC line. Pt admitted to hospital on 4/18/21 with acute basal ganglia hemorrhagic CVA, with PICC line placement on admission. DVTs identified on 4/21 via ultrasound. Pt currently admitted to Hospital


VAERS ID: 1242735 (history)  
Form: Version 2.0  
Age: 28.0  
Sex: Male  
Location: Nebraska  
Vaccinated:2021-04-10
Onset:2021-04-20
   Days after vaccination:10
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / 1 LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Angiogram cerebral abnormal, Cerebral venous sinus thrombosis, Computerised tomogram head abnormal, Electronic cigarette user, Eye pain, Fibrin D dimer, Full blood count, International normalised ratio increased, Magnetic resonance imaging head abnormal, Metabolic function test, Migraine, Platelet count decreased, Scan with contrast, Thrombocytopenia, Venogram abnormal, Vision blurred, Vomiting, White matter lesion
SMQs:, Liver-related coagulation and bleeding disturbances (narrow), Acute pancreatitis (broad), Haematopoietic thrombocytopenia (narrow), Haemorrhage laboratory terms (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Glaucoma (broad), Lens disorders (broad), Retinal disorders (broad), Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (narrow), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: OTC: Multiviatmin tablet by mouth daily, fish oil capsule by mouth daily, creatine poweder - frequency unknown Precription: None
Current Illness: None reported.
Preexisting Conditions: None reported
Allergies: NO known drug allergies
Diagnostic Lab Data: 4/21/2021 @ 1659 Platelets 66 D-Dimer Qunantatative $g 12,800 INR 1.2 CT of head without contrast: 1. Fairly abnormal CT of the head with patchy areas of abnormal attenuation throughout the white matter, which may represent edema. 2. Dense-appearing superior sagittal sinus, potentially representing venous thrombosis. 3. Recommend a contrast-enhanced MRI of the brain, as well as an MRV of the brain. 4. The findings were called at 6:15 PM MRI Brain with and without Contrast: 1. The findings are most consistent with venous thrombosis with involvement of the right jugular, right transverse sinus and superior sagittal sinus. 2. There is patchy edematous change within the subcortical white matter areas bilaterally and symmetrically. No CVA. 3. The findings are called at 8:15 PM. MRI Angiogram Heat without Contrast: 1. The findings are most consistent with venous thrombosis with involvement of the right jugular, right transverse sinus and superior sagittal sinus. 2. There is patchy edematous change within the subcortical white matter areas bilaterally and symmetrically. No CVA. 3. The findings are called at 8:15 PM.
CDC Split Type:

Write-up: ED NOTE is as follows...from 4/21/21 @ 21:47 a 28 y.o. male who to the emergency room with reports of a headache for the last 48 hours. He reports this as being one of the worst headaches he has ever had. He was seen at urgent care and given Toradol, Zofran and Benadryl and still rates his pain an 8 out of 10. He does feel pressure behind his eyes. And reports vomiting in the parking lot at urgent care. He denies abdominal pain back pain, neck pain, shortness of breath, chest pain, numbness or tingling or any other worsening concerns. Reports that he did receive a recent Johnson & Johnson vaccination. Patient states he does vape. He occasionally drinks alcohol he denies any illicit drugs. Patient denies any head trauma. Diagnosis management comments: This is a 28-year-old male arrives to the emergency room with reported migraine headache for the last 48 hours. He did report that he was go to urgent care in which he received a migraine cocktail of Zofran, Benadryl and Toradol. Patient reported that his headache was not resolved so urgent care sent him on for further evaluation. Patient upon arrival had a negative neurological exam however he did report that he had pressure behind his eyes. Was unable to see any papilledema on funduscopic exam. Check patient''s pressures bilaterally and they were 21 and 18. Patient did report to me that this was the worst headache of his life. I did administer IV fluids here as well as Tylenol and morphine. Patient did report some improvement. Patient did report in his past medical history had a recent Johnson & Johnson vaccination. A CBC and CMP was obtained. Did have thrombocytopenia with a count of 66. Since my exam was PERRL with normal extraocular movements. He had no eye redness or eye pain. Of low concerns for any iritis or uveitis. Patient''s patient CT of his head did show a abnormal CT that had a dense appearing superior sagittal sinus that was representing a venous thrombosis. Radiologist did recommend a MRI MRV. An MRI and MRV was ordered. Patient MRI MRv did show findings are consistent with a venous thrombosis involving the right jugular right transverse sinus and superior sagittal sinus there is also a patchy edematous change within the subcortical white matter areas bilaterally and symmetrically. There was no CVA. With patient''s reported migraine headache. Reported blurred vision, low platelets, recent vaccination I do believe patient has vaccine induced thrombotic thrombocytopenia. With this finding I did converse with my overseeing physician Calls were made out to neurology and then a call out did prefer to have patient started on IVIG at 1 g/kg daily for 2 days and blood thinner Xarelto 15 mg p.o. twice daily. These orders were initiated. Internal med services was consulted and with conversations of family, internal med services out possible transfer that an interventionalists could be available if patient needed it. Report was given at 2100 upon my end of shift.


VAERS ID: 1243087 (history)  
Form: Version 2.0  
Age: 66.0  
Sex: Female  
Location: Massachusetts  
Vaccinated:2021-03-01
Onset:2021-04-22
   Days after vaccination:52
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 UN / IM

Administered by: Private       Purchased by: ?
Symptoms: Angiogram cerebral abnormal, Cerebral haemorrhage, Cerebral venous thrombosis, Computerised tomogram, Intensive care
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: B12, Ibuprofen, Loratadine, Raloxifene, D3
Current Illness:
Preexisting Conditions: osteoarthritis
Allergies: Amplicillin, cephalexin, clindamycin
Diagnostic Lab Data: 4/21 CT, CTA brain with above.
CDC Split Type:

Write-up: Cortical sinus thrombosis with intracerebral hemorrhage, seizures. Admitted to ICU.


VAERS ID: 1243194 (history)  
Form: Version 2.0  
Age: 63.0  
Sex: Male  
Location: Minnesota  
Vaccinated:2021-03-10
Onset:2021-03-23
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Blood creatinine normal, Glycosylated haemoglobin normal, Haemoglobin normal, Peripheral swelling, Platelet count decreased, Thrombophlebitis superficial, Ultrasound scan, White blood cell count normal
SMQs:, Cardiac failure (broad), Angioedema (broad), Haematopoietic thrombocytopenia (narrow), Systemic lupus erythematosus (broad), Embolic and thrombotic events, venous (narrow), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Aspirin 325 mg, atorvastatin 80 mg, metoprolol 50 mg, phenytoin 300 mg BID, taldalafil prn
Current Illness: none
Preexisting Conditions: Heterozygous factor V, history of Pulmonary embolism, prediabetes, obesity, coronary artery disease with CABG in 2012. hypertension
Allergies: none
Diagnostic Lab Data: Ultrasound of the leg 3/25/21, baseline labs with platelets of 131, hemoglobin 17.3, WBC 7.9, creatinine 1.0, hemoglobin A1C 5.6
CDC Split Type:

Write-up: Patient had the Janssen vaccine as noted. He presented with significant superficial clot in the lower leg. Ultrasound read Mixed partially occlusive and occlusive superficial venous thrombosis in the right greater saphenous vein. This originates 2.2 cm from the junction with the right common femoral vein. He presented with 2 days of leg swelling without clear trigger such as travel, trauma etc.


VAERS ID: 1245230 (history)  
Form: Version 2.0  
Age: 46.0  
Sex: Female  
Location: Washington  
Vaccinated:2021-04-09
Onset:2021-04-22
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-04-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 042A21A / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Anticoagulant therapy, Condition aggravated, Cor pulmonale, Deep vein thrombosis, Embolism venous, Myocardial strain, Platelet count normal, Pulmonary embolism
SMQs:, Cardiac failure (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Pulmonary hypertension (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Acetaminophen PRN, aripiprazole 1mg qday, buproprion XL 150mg qday, duloxetine 60mg qday, Flonase nasal 2 sp qday, ibuprofen PRN, naproxen PRN, propranolol LA 160mg qday
Current Illness:
Preexisting Conditions: 1. H/o R PE, provoked 2014 after transcontinental flight, s/p Warfarin x 6 months, reportedly negative hypercoagulable panel; with strong family history of venous thrombosis in mother and sister (+ hypercoagulable state, specific type unrecalled to patient) 2. OSA with morbid obesity, nocturnal hypoxemia; on CPAP 3. Asthma, mild intermittent 4. Hypertension 5. Depression, Panic disorder, IBS 6. Allergic rhinitis 7. Intermittent migraine headaches 8. Endometriosis, Ovarian cyst
Allergies: Codeine
Diagnostic Lab Data: Plt 280 (4/22/21)
CDC Split Type:

Write-up: Patient received J&J COVID vaccine on 4/9/21 at pharmacy . Today (4/22/21), patient is admitted to our facility with VTE, submassive, unprovoked, with bilateral high-burden PE and LLE DVT, and right heart strain / acute cor pulmonale; in patient with H/o R PE, provoked 2014 after transcontinental flight, s/p Warfarin x 6 months, reportedly negative hypercoagulable panel; with strong family history of venous thrombosis in mother and sister. Heparin drip started, plan to start DOAC tomorrow. Anticipate hospital admission for at least 2 nights.


VAERS ID: 1246575 (history)  
Form: Version 2.0  
Age: 27.0  
Sex: Female  
Location: Wisconsin  
Vaccinated:2021-04-08
Onset:2021-04-17
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Activated partial thromboplastin time shortened, Blood calcium normal, Blood creatinine normal, Blood fibrinogen increased, Blood potassium normal, Blood sodium normal, Epistaxis, Fatigue, Fibrin D dimer, HIV test negative, Haematocrit normal, Haemoglobin normal, Hepatitis C test negative, Immunoglobulin therapy, International normalised ratio normal, Mean cell volume normal, Mouth haemorrhage, Myalgia, Petechiae, Platelet count decreased, Pyrexia, Vaginal haemorrhage, White blood cell count increased, White blood cell count normal
SMQs:, Rhabdomyolysis/myopathy (broad), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Eosinophilic pneumonia (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: levonorgestrel-ethinyl estradiol -- one tablet by mouth once daily
Current Illness: None
Preexisting Conditions: None
Allergies: No known allergies
Diagnostic Lab Data: 4/17/21 platelets <1000, INR 1.0, PTT 29. WBC 9.9, Hgb 12.9, HCT 38, MCV 88, fibrinogen 402, d-dimer 0.23, heparin level <0.10 4/18/21 platelets <10,000 (patient given prednisone 80 mg daily and IVIG) 4/19/21 platelets 53,000 (discharged on 4/19), WBC 11.2, Hgb 10.7, HCT 32 4/22/21 platelets 186 (this was taken after dischage) 4/17 Sodium, potassium, creatinine, calcium all within normal range. HIV and Hepatitis C negative Discharged on prednisone 80 mg daily with proton pump inhibitor and bactrim and to obtain daily CBC. Instructed to continue oral contraceptive
CDC Split Type:

Write-up: Patient presented on 4/17 to urgent care afer significant vaginal bleeding (soaking through a pad every 1 hour to 1.5 hours) and petechia on multiple extremeties. She also had a nose bleed and bleeding in mouth earlier in the day that resolved spontaneously. After obtaining CBC, platelets were <1000. She was on oral contraceptives. She is a non smoker. She received work up for thrombosis, not indication of thrombosis. She did have some muscle aches and fever and fatigue the day after vaccine. Histroy notable for mild diffuse petechiae on all 4 extremeties. As inpatient received solumedrol 125 mg (then switched to prednisone 80 mg daily), IVIG 1 g/kg x 2 doses. she was discharged on 4/19 d/t rising platelets, Vaginal bleeding slowing and Petechia much fainter.


VAERS ID: 1247196 (history)  
Form: Version 2.0  
Age: 38.0  
Sex: Male  
Location: Florida  
Vaccinated:2021-03-31
Onset:2021-03-31
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-23
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 043A21A / UNK - / -

Administered by: Public       Purchased by: ?
Symptoms: Angiogram, Hypoaesthesia, Intervertebral disc degeneration, Magnetic resonance imaging spinal abnormal, Magnetic resonance imaging thoracic abnormal, Paraesthesia, Venogram
SMQs:, Peripheral neuropathy (broad), Guillain-Barre syndrome (broad), Cardiomyopathy (broad), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: None
Preexisting Conditions:
Allergies: Levaquin
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient states shortly after he received the vaccine, he developed intermittent bilateral upper and extremity numbness/tingling x 2 weeks. CTA/CTV head ruled out cerebral venous sinus thrombosis. MRI cervical, thoracic, and lumbar spines showed degenerative disk disease.


Result pages: prev   3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=12&WRITEUP=thrombosis&VAX=COVID19&VAXTYPES=COVID-19&VAXMAN=JANSSEN

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166